14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
AKTS vs ATOM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ATOM Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 6–2 Matrix Metrics)
ATOM Overall Winner
6-Pillar Tally: AKTS 0 – 5 ATOM (1 Tie)
Matrix Metrics: AKTS 2 – 6 ATOM
As of Nov 16, 2026, Atomera Incorporated (ATOM) is the stronger overall head-to-head candidate over AKTS (AKTS) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). AKTS carries a Unified Composite Score of 30.6/100 (SELL) at $16.49 (N/M Forward P/E, N/A operating margin), whereas ATOM carries 41.2/100 (SELL) at $2.48 (N/M Forward P/E, -10969.4% operating margin).
Defensive Composite Rating Caution: Although ATOM compares more favorably head-to-head, both AKTS (30.6/100 SELL) and ATOM (41.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: AKTS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.1); meanwhile ATOM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKTS vs ATOM. Trailing 12-month operating profitability (AKTS N/A vs ATOM -10969.4%) and valuation multiples (AKTS N/M vs ATOM N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Investor FAQ AKTS vs ATOM Key Questions & Quantitative Answers
As of Nov 16, 2026, Atomera Incorporated (ATOM) is the stronger overall head-to-head candidate over AKTS (AKTS) in the Tradestie Institutional Equity Comparison Engine, winning 6–2 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). AKTS carries a Unified Composite Score of 30.6/100 (SELL) at $16.49 (N/M Forward P/E, N/A operating margin), whereas ATOM carries 41.2/100 (SELL) at $2.48 (N/M Forward P/E, -10969.4% operating margin). Defensive Composite Rating Caution: Although ATOM compares more favorably head-to-head, both AKTS (30.6/100 SELL) and ATOM (41.2/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: AKTS trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 48.1); meanwhile ATOM is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 34.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
ATOM leads the Growth & Scale pillar: AKTS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ATOM at +175.0% YoY revenue growth and +0.0% YoY earnings growth on $219,000 TTM revenue (-29.2% gross margin, -10969.4% operating margin). On trailing 12-month operating scale, AKTS generates N/A in USD-normalized revenue versus $219,000 for ATOM. In operating R&D and SG&A reinvestment, AKTS deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ATOM.
AKTS and ATOM trade at balanced relative valuation multiples. AKTS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ATOM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against AKTS (N/A ROE) versus ATOM (-88.1% ROE) capital efficiency.
In options market volatility and institutional positioning, AKTS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.36β · 66% Vol realized risk). By comparison, ATOM carries 88.9% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.44x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (3.46β · 99% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.